Full notification file
General informationNotification NumberB/NL/12/001Member State to which the notification was sentNetherlandsDate of acknowledgement from the Member State Competent Authority01/08/2012Title of the ProjectMVA-based recombinant influenza vaccines encoding influenza virus hemagglutininsProposed period of release:01/09/2012 to 01/09/2020Name of the Institute(s) or Company(ies)Erasmus MC, Erasmus MC
s-Gravendijkwal 230
Afdeling Urologie
Rotterdam 3015 CE
The Netherlands;
3. Is the same GMO release planned elsewhere in the Community?NoHas the same GMO been notified elsewhere by the same notifier?NoGMO characterizationGMO is a:DNA VirusIdentity of the GMO:Genus: Orthopoxvirus
Species: Modified Vaccinia virus AnkaraInformation relating to the recipient or parental organisms from wich the GMO is derived| Common Name | Genus | Species | Subspecies | Strain | Pathovar | | MVA | orthopoxvirus | vaccinia virus | N/A | Modified Virus Ankara | N/A |
|
European Commission administrative informationConsent given by the Member State Competent Authority:Not known